First quarter consolidated net sales were $10 billion, 18% higher than the prior year, reflecting 9% higher local prices and a net 1% increase due to portfolio changes.
DuPont’s first quarter net income were $1.4 million compared to $1.1 million the prior year, reflecting higher sales volume and selling prices, partly offset by a $171 million decline in pharmaceuticals pre-tax income due to patent expirations.
In the Safety & Protection segment, sales totaled $1 billion, rising 22% and reflecting a 14% volume increase and a 7% increase from a portfolio change. Growth came from increased demand for aramid and nonwoven products in industrial markets across all regions.
In the Performance Coatings sector, sales reached $1 billion, increasing 10%, reflecting 6% higher selling prices and 6% higher volume. Sales increased across all regions, especially in the U.S. and Asia Pacific.